Childhood Mental Health Disorders: Evidence Base and Contextual Factors for Psychosocial, Psychopharmacological, and Combined Interventions
Childhood Mental Health Disorders is a comprehensive report, based on a thorough review of the literature, on the current effective use, sequencing, comparative risks/benefits, and integration of psychotropic medications and psychosocial interventions for children and adolescents. Acknowledging the complexity of these disorders and the need to individualize treatment, the volume is intended as a basic yet comprehensive framework for mental health providers. The disorders addressed include attention deficit/hyperactivity disorder, obsessive–compulsive disorder, autism and schizophrenia, and others.
- Attention-Deficit/Hyperactivity Disorder
- Oppositional Defiant Disorder and Conduct Disorders
- Tourette's and Tic Disorders
- Obsessive–Compulsive Disorder
- Anxiety Disorders
- Depressive Disorders and Suicidality
- Bipolar Disorder
- Schizophrenia Spectrum Disorder
- Autism Spectrum Disorders and Mental Retardation
- Anorexia Nervosa and Bulimia Nervosa
- Elimination Disorders
- Future Directions and Implications
About the Authors
Ronald T. Brown, PhD, ABPP, is professor of public health, psychology, and pediatrics and is dean of the College of Health Professions at Temple University. Dr. Brown is a diplomate in clinical health psychology of the American Board of Professional Psychology and is a fellow of the American Psychological Association (APA), the American Psychological Society, the Society of Behavioral Medicine, and the National Academy of Neuropsychology. Dr. Brown has been the recipient of numerous grant awards from the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense, and the Office of Special Education and Rehabilitation Services.
Dr. Brown currently is the editor of the Journal of Pediatric Psychology and serves on the study section of the Behavioral Medicine and Intervention Outcomes of the Center for Scientific Review of the National Institutes of Health. He has published over 200 articles, chapters, and books related to childhood psychopathology and health psychology. He also has served on the editorial boards of 11 journals related to child and adolescent psychopathology.
Dr. Brown serves as a liaison to the American Academy of Pediatrics' subcommittee on the assessment and practice guidelines for attention-deficit/hyperactivity disorder (ADHD), is chair of the Board of Scientific Affairs of the APA, and serves on the Council of Representatives of the APA.
David O. Antonuccio, PhD, ABPP, is a professor in the Department of Psychiatry and Behavioral Sciences at the University of Nevada School of Medicine. He served on the Nevada State Board of Psychological Examiners from 1990 to 1998. A fellow of the APA and an ABPP diplomate in clinical psychology, Dr. Antonuccio is internationally known for his work on depression and smoking cessation. His articles on the comparative effects of psychotherapy and pharmacotherapy have received extensive coverage by the national media and are models of careful scholarship.
He was named Outstanding Psychologist by the Nevada State Psychological Association (NSPA) in 1993, received an award of achievement in 1999 from NSPA for his work on depression, was awarded the 2000 McReynolds Foundation Psychological Services Award for "outstanding contributions to clinical science," and received the Bud Ogel Award for Distinguished Achievement in Research in 2006 from the Association for Psychologists in Academic Health Settings.
George J. DuPaul, PhD, is professor of school psychology and associate chairperson of the Department of Education and Human Services at Lehigh University. He has extensive experience providing clinical services to children with ADHD and their families as well as consulting with a variety of school districts regarding the management of students with ADHD. He has been an author or coauthor on over 140 journal articles and book chapters related to ADHD and has published 4 books and 2 videos on the assessment and treatment of ADHD. He is currently investigating the effects of early intervention and school-based interventions for students with ADHD as well as the assessment and treatment of college students with ADHD.
Mary A. Fristad, PhD, ABPP, is professor of psychiatry and psychology at the Ohio State University (OSU), where she has been on the faculty since 1986. She is director of Research and Psychological Services in the OSU Division of Child and Adolescent Psychiatry. Dr. Fristad has published over 125 articles and book chapters addressing the assessment and treatment of childhood-onset depression, suicidality, and bipolar disorder. She has edited the Handbook of Serious Emotional Disturbance in Children and Adolescents and cowritten Raising a Moody Child: How to Cope With Depression and Bipolar Disorder.
Dr. Fristad has served on multiple National Institute of Mental Health review committees, the executive board for the APA's Society of Clinical Child and Adolescent Psychology (Division 53), several APA task forces, and the board of directors for five Web-based education and support groups for children and families with mood disorders. She has been the principal or coprincipal investigator on over two dozen federal, state, and local grants.
Cheryl A. King, PhD, ABPP, is chief psychologist in the Department of Psychiatry at the University of Michigan Medical School, where she also serves as director of the Youth Depression and Suicide Prevention Program. As associate professor in the Department of Psychiatry and Psychology at the University of Michigan, Dr. King has an extensive history of National Institute of Mental Health and private foundation funding for her research with suicidal and depressed adolescents. The author of numerous scientific publications, Dr. King serves on several editorial boards and is a frequent reviewer of grant applications in her area of specialization.
Dr. King is past president of the American Association of Suicidology, president of the Association of Psychologists in Academic Health Centers, and president-elect of the Society for Clinical Child and Adolescent Psychology. In addition to her active involvement in professional training and research mentorship activities, she is active in public policy initiatives related to youth suicide prevention.
Laurel K. Leslie, MD, MPH, is the associate director of the Center on Child and Family Outcomes at Tufts–New England Medical Center. Dr. Leslie's research interests focus on the identification and treatment of developmental and mental health needs of children and adolescents across the health, mental health, and school sectors; the impact of guidelines and policy initiatives on youth service use and outcomes; and collaborative models of care across sectors that incorporate the child and family as active participants in care.
Dr. Leslie's expertise in behavioral and developmental pediatrics is recognized nationally; work with the American Academy of Pediatrics and National Initiative on Children's Healthcare Quality includes development of an ADHD tool kit; the Education in Quality Improvement for Pediatric Practice interactive, Web-based continuing medical education module on ADHD; the Pediatric Leadership Alliance; and the American Board of Pediatrics' current Residency Review and Redesign Project.
Gabriele S. McCormick is a writer, editor, and former staff member of the APA. She has collaborated on books, reports, and journal articles dealing with women's issues, particularly depression and women's health, and issues affecting children, youth, and families. She coordinated the Summit on Women and Depression (2000), bringing together internationally renowned experts from a variety of disciplines to provide a state-of-the-art review of research findings, make recommendations for health policy and practice, and generate a research agenda. She also edited the resulting report.
Ms. McCormick provided staff support for the Task Force on Psychotropic Medications for Children and Adolescents, the Task Force on Psychology's Agenda for Child and Adolescent Mental Health, and the Task Force on Adolescent Girls. She edited reports for these groups and coauthored A New Look at Adolescent Girls: Strengths and Stresses: Research Agenda. Ms. McCormick also contributed to the editing of the Report of the Task Force on the Sexualization of Girls.
William E. Pelham Jr., PhD, is a graduate of Dartmouth College and earned his PhD in clinical psychology from the State University of New York at Stony Brook in 1976. He is currently distinguished professor of psychology, pediatrics, and psychiatry at the State University of New York at Buffalo (UB) and director of the Center for Children and Families at UB. His summer treatment program for ADHD children has been recognized by the APA, the Substance Abuse and Mental Health Services Administration, and Children and Adults With Attention-Deficit/Hyperactivity Disorder (CHADD) as a model program and is widely recognized as the state of the art in treatment for ADHD.
Dr. Pelham has authored or coauthored more than 275 professional papers dealing with ADHD and its assessment and treatment—psychosocial, pharmacological, and combined. He has held more than 40 research grants from federal agencies (National Institute of Mental Health [NIMH], National Institute on Alcohol Abuse and Alcoholism [NIAAA], National Institute on Drug Abuse [NIDA], National Institute of Neurological Disorders and Stroke, Institute of Education Services), foundations, and pharmaceutical companies.
He has served as a consultant-advisor on ADHD and related topics to numerous federal agencies (NIMH, NIAAA, NIDA, Institute of Medicine, Office of Medical Applications of Research, and the Centers for Disease Control and Prevention) and organizations (American Academy of Pediatrics, American Academy of Child and Adolescent Psychiatry, APA, CHADD). He founded and directs the biennial Niagara Conference on Evidence-Based Treatments for Childhood and Adolescent Mental Health Problems.
John C. Piacentini, PhD, ABPP, is professor of psychiatry and biobehavioral sciences in the David Geffen School of Medicine and director of the Child OCD, Anxiety, and Tic Disorders Program at the Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles. He received his PhD in clinical psychology from the University of Georgia and completed postdoctoral training and was a faculty member at Columbia University/New York State Psychiatric Institute.
Dr. Piacentini has authored over 125 papers, chapters, and books and has received numerous National Institutes of Health and other grants addressing the etiology, assessment, and treatment of childhood anxiety and obsessive-compulsive disorder, tic disorders, and adolescent suicide. He is a founding fellow of the Academy of Cognitive Therapy and a member of the American Board of Clinical Child and Adolescent Psychology. He is also deputy editor for the Journal of the American Academy of Child & Adolescent Psychiatry and an editorial board member for several leading psychology journals.
Benedetto Vitiello, MD, is a psychiatrist with expertise in psychopharmacology and treatment research. He has been with the National Institute of Mental Health since 1989 and is currently the chief of the Child and Adolescent Treatment and Preventive Interventions Research Branch. He has been involved in clinical trials in various areas, including child, adolescent, adult, and geriatric psychiatry, and in patients with HIV infection. He has been part of many publicly funded clinical trials testing the effects of interventions in children and adolescents, such as the Multimodal Treatment of Children With Attention Deficit Hyperactivity Disorder, the Treatment for Adolescents with Depression Study, the Research Units on Pediatric Psychopharmacology network studies, the Preschoolers With ADHD Treatment Study, and the Treatment of Early Onset Schizophrenia Study. Dr. Vitiello has authored or coauthored about 200 scientific publications, of which about 150 appear in peer-reviewed journals.
This seminal volume covers currently available information on the effective use of treatment modalities, sequencing, comparative risks and benefits, the integration of psychotropic medications, as well as psychosocial interventions for children and adolescents…An impressively informed and informative body of analytical commentary…
—Midwest Book Review